KLSE (MYR): BAT (4162)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
8.39
Today's Change
-0.08 (0.94%)
Day's Change
8.38 - 8.46
Trading Volume
147,600
Market Cap
2,396 Million
NOSH
286 Million
Latest Quarter
31-Dec-2023 [#4]
Announcement Date
06-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
29-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
-20.44% | -23.27%
Revenue | NP to SH
2,310,999.000 | 194,747.000
RPS | P/RPS
809.37 Cent | 1.04
EPS | P/E | EY
68.21 Cent | 12.30 | 8.13%
DPS | DY | Payout %
63.00 Cent | 7.51% | 92.37%
NAPS | P/NAPS
1.32 | 6.36
QoQ | YoY
-6.87% | -25.82%
NP Margin | ROE
8.43% | 51.67%
F.Y. | Ann. Date
31-Dec-2023 | 06-Feb-2024
Latest Audited Result
31-Dec-2023
Announcement Date
03-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
03-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
2,310,999.000 | 194,748.000
RPS | P/RPS
809.37 Cent | 1.04
EPS | P/E | EY
68.20 Cent | 12.30 | 8.13%
DPS | DY | Payout %
63.00 Cent | 7.51% | 92.37%
NAPS | P/NAPS
1.32 | 6.36
YoY
-25.82%
NP Margin | ROE
8.43% | 51.67%
F.Y. | Ann. Date
31-Dec-2023 | 06-Feb-2024
Revenue | NP to SH
2,310,999.000 | 194,748.000
RPS | P/RPS
809.37 Cent | 1.04
EPS | P/E | EY
68.20 Cent | 12.30 | 8.13%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-0.9% | -25.82%
NP Margin | ROE
8.43% | 51.67%
F.Y. | Ann. Date
31-Dec-2023 | 06-Feb-2024
Last 10 FY Result | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2,310,999 | 2,310,999 | 2,310,999 | 2,596,574 | 2,637,255 | 2,315,481 | 2,508,554 | 2,822,946 | 3,002,259 | 3,756,392 | 4,581,547 | 4,795,991 | -7.78% | |
PBT | 256,339 | 256,338 | 256,339 | 385,412 | 394,117 | 329,285 | 462,254 | 623,009 | 639,225 | 908,457 | 1,230,998 | 1,218,797 | -15.89% | |
Tax | -61,591 | -61,591 | -61,591 | -122,893 | -109,256 | -87,446 | -116,555 | -154,478 | -146,590 | -187,168 | -320,936 | -316,766 | -16.62% | |
NP | 194,748 | 194,747 | 194,748 | 262,519 | 284,861 | 241,839 | 345,699 | 468,531 | 492,635 | 721,289 | 910,062 | 902,031 | -15.65% | |
- | ||||||||||||||
NP to SH | 194,748 | 194,747 | 194,748 | 262,519 | 284,861 | 241,839 | 343,814 | 468,531 | 479,688 | 732,066 | 913,305 | 898,125 | -15.61% | |
- | ||||||||||||||
Tax Rate | 24.03% | 24.03% | 24.03% | 31.89% | 27.72% | 26.56% | 25.21% | 24.80% | 22.93% | 20.60% | 26.07% | 25.99% | - | |
Total Cost | 2,116,251 | 2,116,252 | 2,116,251 | 2,334,055 | 2,352,394 | 2,073,642 | 2,162,855 | 2,354,415 | 2,509,624 | 3,035,103 | 3,671,485 | 3,893,960 | -6.54% | |
- | ||||||||||||||
Net Worth | 376,899 | 376,899 | 376,899 | 376,899 | 382,610 | 374,044 | 388,320 | 422,584 | 382,610 | 613,889 | 545,362 | 525,375 | -3.62% |
Dividend | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Div | 179,883 | 179,883 | 179,883 | 251,266 | 279,819 | 236,989 | 336,925 | 442,571 | 482,545 | 793,773 | 890,853 | 222,713 | -2.34% | |
Div Payout % | 92.37% | 92.37% | 92.37% | 95.71% | 98.23% | 97.99% | 98.00% | 94.46% | 100.60% | 108.43% | 97.54% | 24.80% | - |
Equity | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Worth | 376,899 | 376,899 | 376,899 | 376,899 | 382,610 | 374,044 | 388,320 | 422,584 | 382,610 | 613,889 | 545,362 | 525,375 | -3.62% | |
NOSH | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 285,530 | 0.00% |
Ratio Analysis | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NP Margin | 8.43% | 8.43% | 8.43% | 10.11% | 10.80% | 10.44% | 13.78% | 16.60% | 16.41% | 19.20% | 19.86% | 18.81% | - | |
ROE | 51.67% | 51.67% | 51.67% | 69.65% | 74.45% | 64.66% | 88.54% | 110.87% | 125.37% | 119.25% | 167.47% | 170.95% | - |
Per Share | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 809.37 | 809.37 | 809.37 | 909.39 | 923.64 | 810.94 | 878.56 | 988.67 | 1,051.47 | 1,315.59 | 1,604.58 | 1,679.68 | -7.78% | |
EPS | 68.20 | 68.21 | 68.20 | 91.90 | 99.80 | 84.70 | 121.10 | 164.10 | 172.50 | 252.60 | 318.70 | 315.90 | -15.65% | |
DPS | 63.00 | 63.00 | 63.00 | 88.00 | 98.00 | 83.00 | 118.00 | 155.00 | 169.00 | 278.00 | 312.00 | 78.00 | -2.34% | |
NAPS | 1.32 | 1.32 | 1.32 | 1.32 | 1.34 | 1.31 | 1.36 | 1.48 | 1.34 | 2.15 | 1.91 | 1.84 | -3.62% |
Adjusted Per Share Value based on latest NOSH - 285,530 | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 809.37 | 809.37 | 809.37 | 909.39 | 923.64 | 810.94 | 878.56 | 988.67 | 1,051.47 | 1,315.59 | 1,604.58 | 1,679.68 | -7.78% | |
EPS | 68.20 | 68.21 | 68.20 | 91.90 | 99.80 | 84.70 | 121.10 | 164.10 | 172.50 | 252.60 | 318.70 | 315.90 | -15.65% | |
DPS | 63.00 | 63.00 | 63.00 | 88.00 | 98.00 | 83.00 | 118.00 | 155.00 | 169.00 | 278.00 | 312.00 | 78.00 | -2.34% | |
NAPS | 1.32 | 1.32 | 1.32 | 1.32 | 1.34 | 1.31 | 1.36 | 1.48 | 1.34 | 2.15 | 1.91 | 1.84 | -3.62% |
Price Multiplier on Financial Quarter End Date | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 29/12/23 | 29/12/23 | 29/12/23 | 30/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 29/12/17 | 30/12/16 | 31/12/15 | 31/12/14 | - | |
Price | 9.29 | 9.29 | 9.29 | 11.22 | 13.98 | 14.08 | 15.08 | 36.08 | 40.00 | 44.60 | 56.08 | 65.10 | - | |
P/RPS | 1.15 | 1.15 | 1.15 | 1.23 | 1.51 | 1.74 | 1.72 | 3.65 | 3.80 | 3.39 | 3.50 | 3.88 | -12.63% | |
P/EPS | 13.62 | 13.62 | 13.62 | 12.20 | 14.01 | 16.62 | 12.52 | 21.99 | 23.81 | 17.40 | 17.53 | 20.70 | -4.54% | |
EY | 7.34 | 7.34 | 7.34 | 8.19 | 7.14 | 6.02 | 7.98 | 4.55 | 4.20 | 5.75 | 5.70 | 4.83 | 4.75% | |
DY | 6.78 | 6.78 | 6.78 | 7.84 | 7.01 | 5.89 | 7.82 | 4.30 | 4.23 | 6.23 | 5.56 | 1.20 | 21.20% | |
P/NAPS | 7.04 | 7.04 | 7.04 | 8.50 | 10.43 | 10.75 | 11.09 | 24.38 | 29.85 | 20.74 | 29.36 | 35.38 | -16.41% |
Price Multiplier on Announcement Date | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 06/02/24 | 06/02/24 | 06/02/24 | 08/02/23 | 08/02/22 | 10/02/21 | 20/02/20 | 21/02/19 | 13/02/18 | 16/02/17 | 17/02/16 | 16/02/15 | - | |
Price | 9.08 | 9.08 | 9.08 | 12.80 | 12.40 | 13.16 | 12.70 | 37.30 | 32.88 | 48.78 | 56.08 | 70.60 | - | |
P/RPS | 1.12 | 1.12 | 1.12 | 1.41 | 1.34 | 1.62 | 1.45 | 3.77 | 3.13 | 3.71 | 3.50 | 4.20 | -13.65% | |
P/EPS | 13.31 | 13.31 | 13.31 | 13.92 | 12.43 | 15.54 | 10.55 | 22.73 | 19.57 | 19.03 | 17.53 | 22.45 | -5.63% | |
EY | 7.51 | 7.51 | 7.51 | 7.18 | 8.05 | 6.44 | 9.48 | 4.40 | 5.11 | 5.26 | 5.70 | 4.46 | 5.95% | |
DY | 6.94 | 6.94 | 6.94 | 6.88 | 7.90 | 6.31 | 9.29 | 4.16 | 5.14 | 5.70 | 5.56 | 1.10 | 22.69% | |
P/NAPS | 6.88 | 6.88 | 6.88 | 9.70 | 9.25 | 10.05 | 9.34 | 25.20 | 24.54 | 22.69 | 29.36 | 38.37 | -17.37% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Proceed from land sale to Microsoft already received in Feb. Proceed from the other 2 land sales expected o come in by 3rd quarter. Profit from land sales will cushion capital expenditure, and further 100 acres industrial land in NCIP disposal may be materialized within this year. So another 500 million from land sales is awaiting. No point keeping so much cash unless go for further landbanking exercise.
1 month ago
Thank you KS55..
I won't buy just for dividend. I buy for dividends and potential capital gains. I don't know much about Crescendo.
Buying Bat at 10, get some mini dividends but suffer capital loss is not my cup of tea.
Thanks.
1 month ago
big shark push n run.....those who bought 10.00...12.00....15.00 above call : long long log term invest......when rebound ???? wait...........syndicate..n goreng kaki...not santa claus,not 财神爷。。。。。don't imagine this counter return like past...
1 month ago
200 years old mother company just too easily to sorrow the any big or small shark baby bl
1 month ago
those unbelieve...pls buy more now......don't fight with market...we are ikan billis...no more to lost.....
4 weeks ago
Bat is heavly prices manupulated after ff under holding, now bat buying back is in the picture again and to cut the floating
3 weeks ago
Operators doing this, how to go up? See for yourself…
https://youtube.com/shorts/BJkZSSZYGWs?si=CfeT34lCw_ynsaB2
2 weeks ago
Teenagers smoke vape nowadays. Consequently, most people suffering from adverse effects from vape or e-cigarettes will head to the hospital first 😗
https://www.freemalaysiatoday.com/category/nation/2024/03/27/vape-e-cigarette-emergencies-surge-five-fold-over-4-years-says-poison-centre/
2 weeks ago
Why EPF don't support PM-X call buy domestic stocks? BAT DY 7-8% better than EPF 5.5% 2023 dividend.
2 weeks ago
Higher BAT sales(increased price) translate to higher tax collection for government.
2 weeks ago
https://www.nst.com.my/news/crime-courts/2024/03/1031890/macc-arrests-34-customs-officers-rm2-billion-smuggling-scheme
--------------------------------
Cut-off in illegal Cigs will happen in 1Q24
2 weeks ago
I have Not see any "Agent" in Port Klang Custom area.....Anyway many Taiko are no-where to be seen
2 weeks ago
https://www.malaysiakini.com/news/701289
-------------------------------------
You can Expect MACC to comb every corners in Custom Depts Under Anwar's Order
2 weeks ago
AGM-8/5/24 any1 attending? Can we vote no to directors election? Current directors seem don"t care BAT share price drop.
2 weeks ago
Haha. All resolutions will decided by bat holding company as largest shareholder 50.1% even we all say NO.
2 weeks ago
Be careful after ex-date?? Its ex-date was 5 Mar and need to be careful when BAT is moving up? 🤔😂
1 week ago
And bay drop from around 40 to now you still scared, I have all in , talking down is not working on me or I maybe wrong let see from here
1 week ago
There’s no doubt combustible is on the downtrend worldwide and e-vape is showing upwards worldwide very strong, positioning now or never
1 week ago
ks55
Crescendo going to announce Q4 result by end of this month. Predict it will make a total 20 sen from normal business operation after tax. Since there was no interim dividend paid, couple with extra ordinary gain from land disposal, there is no need to retain more cash then necessary. Expecting it to declare not less than 20 sen per share by end of the month.
1 month ago